Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, SYNOPSYS INC insiders sold a net $59.6M of stock across 146 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Sep 15, 2026.
The trade is 19.0% of the 76,865 shares held after it.
2 other insiders sold within 30 days.
781 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: PRESIDENT AND CEO Ghazi Sassine sold about $6.8M of SNPS under a 10b5-1 plan on Oct 15, 2026; 2 other insiders sold within 30 days and 781 funds added in the latest 13F quarter.
12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on Oct 5, 2026.
The trade is 40.4% of the 22,717 shares held after it.
2 other insiders sold within 30 days.
781 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Deputy CFO & CAO Kankanwadi Sudhindra sold about $4.6M of SNPS on Oct 6, 2026; 2 other insiders sold within 30 days and 781 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jan 12, 2026.
The trade is 3.4% of the 17,094 shares held after it.
2 other insiders sold within 30 days.
781 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: GC & Corporate Secretary LEE JANET sold about $293.3K of SNPS on Oct 6, 2026; 2 other insiders sold within 30 days and 781 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jan 12, 2026.
The trade is 3.4% of the 16,534 shares held after it.
2 other insiders sold within 30 days.
781 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: GC & Corporate Secretary LEE JANET sold about $281.3K of SNPS on Oct 6, 2026; 2 other insiders sold within 30 days and 781 funds added in the latest 13F quarter.
11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Sep 22, 2025.
The trade is 13.2% of the 22,717 shares held after it.
2 other insiders sold within 30 days.
781 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Deputy CFO & CAO Kankanwadi Sudhindra sold about $1.5M of SNPS on Oct 5, 2026; 2 other insiders sold within 30 days and 781 funds added in the latest 13F quarter.
146 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SNPS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
SASSINE E GHAZI
Filed 2026-10-15
$6.8M
SUDHINDRA KANKANWADI
Filed 2026-10-06
$4.6M
JANET LEE
Filed 2026-10-06
$574.9K
SUDHINDRA KANKANWADI
Filed 2026-10-05
$1.5M
SASSINE E GHAZI
Filed 2026-09-15
$5.5M
SNPS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Edgewood Growth Fund
$121.7M position · as of 2026-06-30
6.2%
13D Activist Fund
$5.6M position · as of 2026-06-30
4.9%
The 3D Printing ETF
$2.7M position · as of 2026-07-31
4.7%
VanEck Fabless Semiconductor ETF
$12.0M position · as of 2026-06-30
4.1%
Formidable Fortress ETF
$794.0K position · as of 2026-06-30
3.7%
Victory Pioneer Fundamental Growth Fund
$230.7M position · as of 2026-06-30
3.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Synopsys, Inc. Political Action Committee (Synopsys Pac)
Cycle 2026 · $40K spent
$20.3K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Aart J.De Geus
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$12.7M
$34.1M
$7.8M
+114%
+51%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $59.6M sold by insiders over 180 days, 781 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $53.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$9.4B
four quarters, 2025-08-01 to 2026-07-31
Revenue, TTM SNPS
FY Oct 2025
$7.1B
FY Oct 2024
n/a
FY Oct 2023
$5.8B
FY Oct 2022
$5.1B
FY Oct 2021
$4.2B
Jul 2026
$2.5B
Apr 2026
$2.3B
Jan 2026
$2.4B
Oct 2025
$2.3B
Jul 2025
$1.7B
Apr 2025
$1.6B
Jan 2025
$1.5B
Oct 2024
$1.6B
At each fiscal year end
Single quarter
Net margin, TTM
+11.4%
net income over revenue, 2025-08-01 to 2026-07-31
Net margin, TTM SNPS
FY Oct 2025
+18.9%
FY Oct 2024
n/a
FY Oct 2023
+21.1%
FY Oct 2022
+19.4%
FY Oct 2021
+18.0%
Jul 2026
+22.0%
Apr 2026
+0.8%
Jan 2026
+2.7%
Oct 2025
+19.9%
Jul 2025
+13.9%
Apr 2025
+21.5%
Jan 2025
+20.3%
Oct 2024
+68.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.7B
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Free cash flow, TTM SNPS
FY Oct 2025
$1.3B
FY Oct 2024
$1.3B
FY Oct 2023
$1.5B
FY Oct 2022
$1.6B
FY Oct 2021
$1.4B
Jul 2026
$746.3M
Apr 2026
$574.7M
Jan 2026
$821.5M
Oct 2025
$605.2M
Jul 2025
$632.4M
Apr 2025
$219.8M
Jan 2025
-$108.2M
Oct 2024
$542.1M
At each fiscal year end
Single quarter
Debt to equity
0.32x
long-term 2026-07-31 plus current 2026-07-31; equity 2026-07-31
Debt to equity SNPS
FY Oct 2025
0.48x
FY Oct 2024
0.00x
FY Oct 2023
0.00x
FY Oct 2022
0.00x
FY Oct 2021
0.02x
Jul 2026
0.32x
Apr 2026
0.33x
Jan 2026
0.33x
Oct 2025
0.48x
Jul 2025
0.52x
Apr 2025
1.01x
Jan 2025
0.00x
Oct 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.29x
TTM operating cash flow over long-term 2026-07-31 plus current 2026-07-31
Cash flow to debt SNPS
FY Oct 2025
0.11x
FY Oct 2024
90.19x
FY Oct 2023
94.22x
FY Oct 2022
83.50x
FY Oct 2021
14.91x
Jul 2026
0.29x
Apr 2026
0.28x
Jan 2026
0.24x
Oct 2025
0.11x
Jul 2025
0.10x
Apr 2025
0.12x
Jan 2025
100.38x
Oct 2024
90.19x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+3.7%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on equity SNPS
FY Oct 2025
+7.1%
FY Oct 2024
+29.9%
FY Oct 2023
+21.1%
FY Oct 2022
+18.2%
FY Oct 2021
+14.8%
Jul 2026
+3.7%
Apr 2026
+3.8%
Jan 2026
+5.5%
Oct 2025
+7.1%
Jul 2025
+11.3%
Apr 2025
+25.3%
Jan 2025
+26.4%
Oct 2024
+29.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.2%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets SNPS
FY Oct 2025
+4.3%
FY Oct 2024
+19.3%
FY Oct 2023
+12.5%
FY Oct 2022
+10.8%
FY Oct 2021
+9.0%
Jul 2026
+2.2%
Apr 2026
+2.2%
Jan 2026
+3.7%
Oct 2025
+4.3%
Jul 2025
+6.7%
Apr 2025
+12.4%
Jan 2025
+17.9%
Oct 2024
+19.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+1.8%
operating income after a 17.2% effective tax rate, over long-term 2026-07-31 plus current 2026-07-31 plus average of 2025-07-31 and 2026-07-31 minus cash
Return on invested capital SNPS
FY Oct 2025
+3.1%
FY Oct 2024
+25.7%
FY Oct 2023
n/a
FY Oct 2022
+25.1%
FY Oct 2021
+17.8%
Jul 2026
+1.8%
Apr 2026
+2.7%
Jan 2026
+3.0%
Oct 2025
+3.1%
Jul 2025
+3.5%
Apr 2025
+11.4%
Jan 2025
+21.2%
Oct 2024
+25.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+1.8%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
Return on capital employed SNPS
FY Oct 2025
+3.3%
FY Oct 2024
+15.3%
FY Oct 2023
+18.2%
FY Oct 2022
+17.7%
FY Oct 2021
+12.0%
Jul 2026
+1.8%
Apr 2026
+1.9%
Jan 2026
+3.2%
Oct 2025
+3.3%
Jul 2025
+4.1%
Apr 2025
+8.7%
Jan 2025
+13.5%
Oct 2024
+15.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
79.43x
close 2026-10-26 over four quarters of diluted EPS, 2025-08-01 to 2026-07-31
P/E, trailing SNPS
FY Oct 2025
56.38x
FY Oct 2024
35.37x
FY Oct 2023
59.27x
FY Oct 2022
46.51x
FY Oct 2021
69.27x
Jul 2026
67.97x
Apr 2026
110.18x
Jan 2026
71.56x
Oct 2025
56.38x
Jul 2025
49.72x
Apr 2025
33.14x
Jan 2025
38.87x
Oct 2024
35.37x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$93.5B
market value at close 2026-10-26 on 2026-08-24 shares, plus long-term 2026-07-31 plus current 2026-07-31, minus cash 2026-07-31
Enterprise value SNPS
FY Oct 2025
$94.9B
FY Oct 2024
$75.0B
FY Oct 2023
$70.0B
FY Oct 2022
$43.3B
FY Oct 2021
$49.5B
Jul 2026
$80.9B
Apr 2026
$100.1B
Jan 2026
$96.9B
Oct 2025
$94.9B
Jul 2025
$110.1B
Apr 2025
$66.9B
Jan 2025
$77.6B
Oct 2024
$75.0B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield SNPS
FY Oct 2025
+1.6%
FY Oct 2024
+1.6%
FY Oct 2023
+2.1%
FY Oct 2022
+3.6%
FY Oct 2021
+2.8%
Jul 2026
+3.7%
Apr 2026
+2.8%
Jan 2026
+2.6%
Oct 2025
+1.6%
Jul 2025
+1.3%
Apr 2025
+1.5%
Jan 2025
+1.6%
Oct 2024
+1.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -55%, PEG needs growth
PEG, trailing SNPS
FY Oct 2025
n/a
FY Oct 2024
0.42x
FY Oct 2023
2.29x
FY Oct 2022
1.51x
FY Oct 2021
5.37x
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
1.53x
Apr 2025
0.65x
Jan 2025
0.79x
Oct 2024
0.42x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SNPS ranks highest on institutional and government (72nd percentile) and growth (54th), and lowest on insider conviction (10th), among Software & IT peers.
Profitability
44
Inputs
Return on equity+3.7% · 55 pct, sector of 286
Return on assets+2.2% · 63 pct, sector of 381
Return on invested capital+1.8% · 4 pct, sector of 78
Return on capital employed+1.8% · 56 pct, sector of 294
Financial health
47
Inputs
Debt to equity0.32x · 41 pct, sector of 288
Cash flow to debt0.29x · 54 pct, sector of 241
Growth
54
Inputs
Revenue growth, YoY+15.1% · 62 pct, sector of 480
Backlog growth, YoY+7.9% · 45 pct, sector of 182
Insider conviction
10
Inputs
Net Form 4 buying (codes P and S), 180d-$14.8M · 20 pct, sector of 285
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
72
Inputs
Funds adding, latest quarter781 · 96 pct, sector of 415
Congress net buyers, 365d0 · 39 pct, sector of 72
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$2.0M · 82 pct, sector of 85
Risk and compliance
46
Inputs
Short interest, % of float+2.6% · 64 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+17.3% · 28 pct, sector of 316
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SNPS filings, in plain words
Are Synopsys insiders buying or selling SNPS?
In the 180 days to 2026-10-28, Synopsys insiders were net sellers, a net $59.6M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded SNPS?
Yes. In the year to 2026-10-28, 1 House member disclosed buying SNPS and 1 House member disclosed selling it; the latest on record is a purchase by Dan Newhouse dated 2025-12-31.
Are there planned insider sales of SNPS?
Yes. 6 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $53.3M of stock; the latest, by SASSINE E GHAZI, was filed 2026-10-15.
Read the full summary
In the 180 days to 2026-10-28, Synopsys insiders were net sellers of SNPS, a net $59.6M across purchases and sales reported on Form 4 by 5 sellers. 45% of the 11 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 1 member of Congress disclosed buying SNPS and 1 member disclosed selling it; the latest on record is a purchase by Dan Newhouse dated 2025-12-31. Insiders filed 6 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $53.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.